KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Debt Ratio (2017 - 2023)

Historic Debt Ratio for Bionano Genomics (BNGO) over the last 7 years, with Q3 2023 value amounting to 0.05.

  • Bionano Genomics' Debt Ratio rose 9128.23% to 0.05 in Q3 2023 from the same period last year, while for Sep 2023 it was 0.05, marking a year-over-year increase of 9128.23%. This contributed to the annual value of 0.03 for FY2022, which is N/A changed from last year.
  • Latest data reveals that Bionano Genomics reported Debt Ratio of 0.05 as of Q3 2023, which was up 9128.23% from 0.04 recorded in Q2 2023.
  • Bionano Genomics' Debt Ratio's 5-year high stood at 1.03 during Q3 2019, with a 5-year trough of 0.03 in Q2 2022.
  • Over the past 5 years, Bionano Genomics' median Debt Ratio value was 0.27 (recorded in 2020), while the average stood at 0.36.
  • As far as peak fluctuations go, Bionano Genomics' Debt Ratio soared by 24973.32% in 2019, and later tumbled by 9565.18% in 2021.
  • Bionano Genomics' Debt Ratio (Quarter) stood at 0.66 in 2019, then tumbled by 59.38% to 0.27 in 2020, then crashed by 85.7% to 0.04 in 2021, then decreased by 21.01% to 0.03 in 2022, then skyrocketed by 80.18% to 0.05 in 2023.
  • Its last three reported values are 0.05 in Q3 2023, 0.04 for Q2 2023, and 0.03 during Q1 2023.